Ardelyx clinical trials we track

Check company identity source

Phase 3 4 trials

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 YrsNCT06553547TenapanorCompleted2026-07-07Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Durable CSBM response. After: Measure: Durable complete spontaneous bowel movements (CSBM) response.

Check registry source